Indication: This product is suitable for the treatment of various tinea, including tinea capitis, tinea barbae, tinea corporis, tinea cruris, tinea pedis and tinea unguium. The above tinea are caused by Trichophyton crimson, Trichophyton tonsurans, Trichophyton mentagrophytes, Trichophyton interdigitalis, etc., as well as Microsporum audouinensis, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum. This product is not suitable for mild, localized superficial fungal infections and those who have been effective with topical antifungal drugs. Griseofulvin is ineffective against infections such as Candida, Histoplasma, Actinomyces, Sporothrix, Blastomyces, Coccidioides, Nocardia and Cryptococcus, as well as tinea versicolor.

Indication: 1. Candidiasis: used to treat oropharyngeal and esophageal candidiasis; disseminated candidiasis, including peritonitis, pneumonia, urinary tract infection, etc.; candidal vulvovaginitis. It can also be used to prevent candidal infections in bone marrow transplant patients receiving cytotoxic drugs or radiotherapy. 2. Cryptococcosis: used to treat new cryptococcosis other than meninges; when treating cryptococcal meningitis, this product can be used as a maintenance therapy after initial treatment with amphotericin B combined with flucytosine. 3. Coccidioidomycosis. 4. This product can also replace itraconazole for the treatment of blastomycosis and histoplasmosis.

Indication: 1. Candidiasis: used to treat oropharyngeal and esophageal Candida infections; disseminated Candidiasis, including peritonitis, pneumonia, urinary tract infections, etc.; Candida vulvovaginitis. It can also be used to prevent Candida infections in bone marrow transplant patients receiving cytotoxic drugs or radiotherapy. 2. Cryptococcosis: used to treat new cryptococcosis other than meninges; when treating cryptococcal meningitis, this product can be used as a maintenance therapy after initial treatment with amphotericin B combined with flucytosine. 3. Coccidioidomycosis. 4. Used for preventive treatment of patients receiving chemotherapy, radiotherapy and immunosuppressive therapy. 5. This product can also replace itraconazole for the treatment of blastomycosis and histoplasmosis.